Chloramphenicol

15
Chloramphenicol

Transcript of Chloramphenicol

Page 1: Chloramphenicol

Chloramphenicol

Page 2: Chloramphenicol

INTRODUCTION

Broad spectrum

(aerobic, anaerobic, gram +, gram -, rickettsiae)

Bacteriostatic

Bactericidal (H.influenzae, Neisseria meningitidis)

Page 3: Chloramphenicol

30S

P A

PROTEIN SYNTHESIS

50S

Step 1 – AA binds to A Step 2 – transpeptidation

Step 3 – tRNA leaves P site Step 4 – translocation

X

Page 4: Chloramphenicol

Inhibits protein synthesis

Binds reversibly to 50S; Inhibits peptidyl transferase

Inhibits transfer of elongating peptide chain to newly

attached aminoacyl tRNA at A site

30S

PROTEIN

SYNTHESIS

P A

XX

Page 5: Chloramphenicol

PHARMACOKINETICS

Dose : 50 - 100 mg/kg/day

Chloramphenicol palmitate (oral)

Chloramphenicol succinate (Parenteral)

THROUGH ORAL ROUTE – COMPLETELY & RAPIDLY ABSORBED

Wide tissue distribution ( body fluids, CSF )

Inactivated by glucuronide conjugation

Eliminated in urine, bile, feces

Page 6: Chloramphenicol

1-10µg/ml - inhibits Gram +ve bacteria

O.2-5µg/ml - inhibits Gram -ve bacteria

Resistance due to

chloramphenicol acetyl transferase

decreased permeability into bacterial cells

Cross resistance seen between

Chloramphenicol, Macrolides, Lincosamide

Page 7: Chloramphenicol

Clinical uses

Typhoid

Typhus

Rocky Mountain Spotted Fever

Meningococcal meningitis

Topically for eye infections

Page 8: Chloramphenicol

HEPATIC FAILURE

NEW BORNS (<1WK)

PREMATURE INFANTS

When

chloramphenicol

should not be

prescribed ?

Page 9: Chloramphenicol

Adverse effects

Nausea, vomiting, diarrhoea,

oral/vaginal candidiasis

Bone marrow disturbances:

dose related reversible suppression of

RBCs

aplastic anemia (idiosyncratic),

irreversible, prolonged use

Gray Baby Syndrome

Page 10: Chloramphenicol

Gray baby syndrome

stops feeding Vomiting Hypotonic Hypothermic Distended abdomen Irregular respiration Ashen gray cyanosis Cardiovascular

collapse Death

Page 11: Chloramphenicol

Why Gray baby syndrome occurs in neonates ?

Inability of neonate to metabolise

& excrete chloramphenicol due to

deficiency of glucuronosyl

transferase

At higher concentration it inhibits

electron transport in liver, heart,

skeletal muscle

Page 12: Chloramphenicol

Avoided by dose reduction

< 50 mg/kg/day ( full term

infants )

< 25 mg/kg/day ( pre term

infants )

Gray baby syndrome

Page 13: Chloramphenicol

DRUG INTERACTION

Inhibits hepatic enzymes

Increases serum level of

Phenytoin, tolbutamide, warfarin

Antagonises action of penicillins,

aminoglycosides

Page 14: Chloramphenicol

Why it is rarely used?

potential toxicity,

bacterial

resistance &

availability of

effective

alternatives

Page 15: Chloramphenicol